These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Phagotherapy: a nightmare for bacteria, a dream for physicians?]. Debarbieux L; Saussereau E; Maura D Biol Aujourdhui; 2013; 207(3):181-90. PubMed ID: 24330971 [TBL] [Abstract][Full Text] [Related]
4. Studies on bacteriophage penetration in patients subjected to phage therapy. Weber-Dabrowska B; Dabrowski M; Slopek S Arch Immunol Ther Exp (Warsz); 1987; 35(5):563-8. PubMed ID: 3332066 [TBL] [Abstract][Full Text] [Related]
5. Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases. Slopek S; Durlakowa I; Weber-Dabrowska B; Dabrowski M; Kucharewicz-Krukowska A Arch Immunol Ther Exp (Warsz); 1984; 32(3):317-35. PubMed ID: 6395825 [TBL] [Abstract][Full Text] [Related]
6. Phage therapy: past history and future prospects. Carlton RM Arch Immunol Ther Exp (Warsz); 1999; 47(5):267-74. PubMed ID: 10604231 [TBL] [Abstract][Full Text] [Related]
7. [Experimental phage therapy in the beginning of the 21st century]. Debarbieux L Med Mal Infect; 2008 Aug; 38(8):421-5. PubMed ID: 18692973 [TBL] [Abstract][Full Text] [Related]
9. [Some immunological changes in children with bacterial infections treated with bacteriophages]. Pagava KI; Metskhvarishvili GD; Gachechiladze KK; Korinteli IA; Khoĭle N; Dzuliashvili MG Georgian Med News; 2012 Nov; (212):64-9. PubMed ID: 23221141 [TBL] [Abstract][Full Text] [Related]
10. Isolation and characterisation of two novel coliphages with high potential to control antibiotic-resistant pathogenic Escherichia coli (EHEC and EPEC). Viscardi M; Perugini AG; Auriemma C; Capuano F; Morabito S; Kim KP; Loessner MJ; Iovane G Int J Antimicrob Agents; 2008 Feb; 31(2):152-7. PubMed ID: 18082374 [TBL] [Abstract][Full Text] [Related]
11. Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results. Slopek S; Durlakowa I; Weber-Dabrowska B; Kucharewicz-Krukowska A; Dabrowski M; Bisikiewicz R Arch Immunol Ther Exp (Warsz); 1983; 31(3):293-327. PubMed ID: 6651485 [TBL] [Abstract][Full Text] [Related]
12. Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. Weber-Dabrowska B; Mulczyk M; Górski A Transplant Proc; 2003 Jun; 35(4):1385-6. PubMed ID: 12826166 [No Abstract] [Full Text] [Related]
13. [Enteric phage-bacterium systems. Incidence of lysogeny and enteric phages in enterobacterial infections. Preliminary note]. Ciucă M; Rusu V; Baron O; Maghearu S Arch Roum Pathol Exp Microbiol; 1964 Sep; 23(3):587-92. PubMed ID: 5318788 [No Abstract] [Full Text] [Related]